Inventor · disambiguated record
Daniel Levy
Also filed as: LEVY DANIEL · LEVY DANIEL E · LEVY DANIEL EMIL
36 granted patents·25 pending applications·662 citations·filing 1993–2025
97Inventor score
Top patents by PatentIndex Score
61 records- 0196US11773097B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2021·Granted Oct 3, 2023·5 cites·17 claims
- 0295US11780840B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Oct 10, 2023·4 cites·12 claims
- 0395US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 0495US5892112AProcess for preparing synthetic matrix metalloprotease inhibitorsGLYCOMED INC·Filed 1994·Granted Apr 6, 1999·177 cites·14 claims
- 0594US11752154B2Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2019·Granted Sep 12, 2023·5 cites·20 claims
- 0693US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 0793US10975088B2Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitorsINCYTE CORP·Filed 2019·Granted Apr 13, 2021·6 cites·13 claims
- 0893US10479795B2Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2018·Granted Nov 19, 2019·13 cites·45 claims
- 0992US11072614B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2017·Granted Jul 27, 2021·8 cites·30 claims
- 1091US7115741B24-thieno[2,3-D]pyrimidin-4-YL piperazine compoundsLEVY DANIEL E·Filed 2002·Granted Oct 3, 2006·41 cites·19 claims
- 1190US11130760B2Polymorphic form of sepiapterinPTC THERAPEUTICS MP INC·Filed 2017·Granted Sep 28, 2021·9 cites·18 claims
- 1290US11046658B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2019·Granted Jun 29, 2021·4 cites·23 claims
- 1390US5789385ASialyl Lewisx mimetics containing phenyl backbonesGLYCOMED INC·Filed 1996·Granted Aug 4, 1998·68 cites·39 claims
- 1489US12173006B2Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitorINCYTE CORP·Filed 2021·Granted Dec 24, 2024·1 cites·12 claims
- 1588US10738057B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·5 cites·38 claims
- 1687US11186580B2Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitorINCYTE CORP·Filed 2019·Granted Nov 30, 2021·4 cites·31 claims
- 1787US6316465B1Ophthalmic uses of PPARgamma agonists and PPARgamma antagonistsPHOTOGENESIS INC·Filed 1999·Granted Nov 13, 2001·78 cites·12 claims
- 1886US5658880ASialic acid/fucose based medicamentsGLYCOMED INC·Filed 1994·Granted Aug 19, 1997·60 cites·48 claims
- 1985US11661422B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted May 30, 2023·1 cites·55 claims
- 2084US12269829B2Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2023·Granted Apr 8, 2025·0 cites·14 claims
- 2184US5654282ASelectin binding glycopeptidesGLYCOMED INC·Filed 1995·Granted Aug 5, 1997·58 cites·19 claims
- 2283US12213982B2Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2023·Granted Feb 4, 2025·0 cites·19 claims
- 2383US6887880B2Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereofMILLENNIUM PHARM INC·Filed 2001·Granted May 3, 2005·22 cites·15 claims
- 2482US2025195526A1Pharmaceutical compositions comprising sepiapterin and uses thereofPTC THERAPEUTICS MP INC·Filed 2024·Application pending·0 cites
- 2582US2025388553A1AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
- 2681US2025320212A1Tricyclic urea compounds as jak2 v617f inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2780US10975111B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2019·Granted Apr 13, 2021·3 cites·16 claims
- 2879US2025243206A1Crystalline forms of a phosphoinositide 3-kinase (pi3k) inhibitorINCYTE CORP·Filed 2024·Application pending·0 cites
- 2978US5773438ASynthetic matrix metalloprotease inhibitors and use thereofGLYCOMED INC·Filed 1994·Granted Jun 30, 1998·36 cites·23 claims
- 3078US2025206774A1C-20 steroid compounds, compositions and uses thereof to treat traumatic brain injury (tbi), including concussionsORAGENICS INC·Filed 2024·Application pending·0 cites
- 3175US12030885B2Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitorsINCYTE CORP·Filed 2021·Granted Jul 9, 2024·0 cites·20 claims
- 3275US11746119B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2021·Granted Sep 5, 2023·0 cites·12 claims
- 3375US2024409576A1-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-ORAGENICS INC·Filed 2023·Application pending·0 cites
- 3474US5837689ASialyl lewis-x mimetics containing naphthyl backbonesGLYCOMED INC·Filed 1996·Granted Nov 17, 1998·40 cites·33 claims
- 3574US2023285386A1IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONSMIND MEDICINE INC·Filed 2023·Application pending·0 cites
- 3672US2025230164A1Polymorphs of sepiapterin and salts thereofPTC THERAPEUTICS MP INC·Filed 2025·Application pending·0 cites
- 3770US12421197B2Aminopyrazine derivatives as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Sep 23, 2025·0 cites·28 claims
- 3866US11643424B2Cardiopathy-reducing phosphodiester lipidsSIGNPATH PHARMA INC·Filed 2021·Granted May 9, 2023·0 cites·14 claims
- 3965US2025228821A1N-desmethyl ruboxistaurin as a kinase inhibitor4M THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4065US2024270765A2Cardioprotective lipids and methods of useSIGNPATH PHARMA INC·Filed 2023·Application pending·0 cites
- 4164US12325706B2Polymorphic form of sepiapterinPTC THERAPEUTICS MP INC·Filed 2021·Granted Jun 10, 2025·0 cites·14 claims
- 4261US2025188069A1Compounds and methods for degrading casein kinase 1 alphaPIN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4360US2011282093A1Heterobifunctional polyethylene glycol reagentsLEVY DANIEL E·Filed 2008·Application pending·0 cites
- 4458US2023042703A1Cardioprotective Lipid and Method of UseSIGNPATH PHARMA INC·Filed 2022·Application pending·0 cites
- 4557US2023303572A118-mc salt formsMIND MEDICINE INC·Filed 2023·Application pending·0 cites
- 4656US2005153319A1Estrogen receptor gene variation and diseaseFiled 2004·Application pending·0 cites
- 4755US2020306297A1Engineered Exosomes for the Delivery of Bioactive Cargo Using Transmembrane VSV-GUNIV SANTA CLARA·Filed 2020·Application pending·0 cites
- 4854US2021180089A1Nanoparticles for transfectionLOXEGEN HOLDINGS PTY LTD·Filed 2019·Application pending·0 cites
- 4953US9951061B2CaMKII inhibitors and uses thereofALLOSTEROS THERAPEUTICS INC·Filed 2014·Granted Apr 24, 2018·1 cites·20 claims
- 5053US2007179123A1Methods and compositions for treating diseases associated with pathogenic proteinsCHIANG PETER K·Filed 2006·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Levy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →